Literature DB >> 22828138

Benzo[a]pyrene (BP) DNA adduct formation in DNA repair-deficient p53 haploinsufficient [Xpa(-/-)p53(+/-)] and wild-type mice fed BP and BP plus chlorophyllin for 28 days.

Kaarthik John1, M Margaret Pratt, Frederick A Beland, Mona I Churchwell, Gail McMullen, Ofelia A Olivero, Igor P Pogribny, Miriam C Poirier.   

Abstract

We have evaluated DNA damage (DNA adduct formation) after feeding benzo[a]pyrene (BP) to wild-type (WT) and cancer-susceptible Xpa(-/-)p53(+/-) mice deficient in nucleotide excision repair and haploinsufficient for the tumor suppressor p53. DNA damage was evaluated by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry (HPLC/ES-MS/MS), which measures r7,t8,t9-trihydroxy-c-10-(N (2)-deoxyguanosyl)-7,8,9,10-tetrahydrobenzo[a]pyrene (BPdG), and a chemiluminescence immunoassay (CIA), using anti-r7,t8-dihydroxy-t-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BPDE)-DNA antiserum, which measures both BPdG and the other stable BP-DNA adducts. When mice were fed 100 ppm BP for 28 days, BP-induced DNA damage measured in esophagus, liver and lung was typically higher in Xpa(-/-)p53(+/-) mice, compared with WT mice. This result is consistent with the previously observed tumor susceptibility of Xpa(-/-)p53(+/-) mice. BPdG, the major DNA adduct associated with tumorigenicity, was the primary DNA adduct formed in esophagus (a target tissue in the mouse), whereas total BP-DNA adducts predominated in higher levels in the liver (a non-target tissue in the mouse). In an attempt to lower BP-induced DNA damage, we fed the WT and Xpa(-/-)p53(+/-) mice 0.3% chlorophyllin (CHL) in the BP-containing diet for 28 days. The addition of CHL resulted in an increase of BP-DNA adducts in esophagus, liver and lung of WT mice, a lowering of BPdG in esophagi of WT mice and livers of Xpa(-/-)p53(+/-) mice and an increase of BPdG in livers of WT mice. Therefore, the addition of CHL to a BP-containing diet showed a lack of consistent chemoprotective effect, indicating that oral CHL administration may not reduce PAH-DNA adduct levels consistently in human organs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22828138      PMCID: PMC3499045          DOI: 10.1093/carcin/bgs247

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  43 in total

1.  Cancer chemoprevention by dietary chlorophylls: a 12,000-animal dose-dose matrix biomarker and tumor study.

Authors:  Tammie J McQuistan; Michael T Simonich; M Margaret Pratt; Cliff B Pereira; Jerry D Hendricks; Roderick H Dashwood; David E Williams; George S Bailey
Journal:  Food Chem Toxicol       Date:  2011-11-03       Impact factor: 6.023

Review 2.  Carcinogen macromolecular adducts and their measurement.

Authors:  M C Poirier; R M Santella; A Weston
Journal:  Carcinogenesis       Date:  2000-03       Impact factor: 4.944

3.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

4.  Chlorophylls as anticarcinogens (review).

Authors:  R Dashwood
Journal:  Int J Oncol       Date:  1997-04       Impact factor: 5.650

Review 5.  The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer.

Authors:  Marianne Farnebo; Vladimir J N Bykov; Klas G Wiman
Journal:  Biochem Biophys Res Commun       Date:  2010-05-21       Impact factor: 3.575

Review 6.  Overview of mechanisms of cancer chemopreventive agents.

Authors:  Silvio De Flora; Lynnette R Ferguson
Journal:  Mutat Res       Date:  2005-08-16       Impact factor: 2.433

7.  Derivative fluorescence spectral analysis of polycyclic aromatic hydrocarbon-DNA adducts in human placenta.

Authors:  A Weston; D K Manchester; M C Poirier; J S Choi; G E Trivers; D L Mann; C C Harris
Journal:  Chem Res Toxicol       Date:  1989 Mar-Apr       Impact factor: 3.739

Review 8.  DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models: implications for DNA adduct-based human cancer risk assessment.

Authors:  M C Poirier; F A Beland
Journal:  Chem Res Toxicol       Date:  1992 Nov-Dec       Impact factor: 3.739

9.  Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA.

Authors:  A de Vries; C T van Oostrom; F M Hofhuis; P M Dortant; R J Berg; F R de Gruijl; P W Wester; C F van Kreijl; P J Capel; H van Steeg; S J Verbeek
Journal:  Nature       Date:  1995-09-14       Impact factor: 49.962

Review 10.  Nucleotide excision repair and cancer.

Authors:  Diana Leibeling; Petra Laspe; Steffen Emmert
Journal:  J Mol Histol       Date:  2006-07-20       Impact factor: 3.156

View more
  3 in total

1.  Mechanistic relationships between hepatic genotoxicity and carcinogenicity in male B6C3F1 mice treated with polycyclic aromatic hydrocarbon mixtures.

Authors:  Tracie D Phillips; Molly Richardson; Yi-Shing Lisa Cheng; Lingyu He; Thomas J McDonald; Leslie H Cizmas; Stephen H Safe; Kirby C Donnelly; Fen Wang; Bhagavatula Moorthy; Guo-Dong Zhou
Journal:  Arch Toxicol       Date:  2014-06-03       Impact factor: 5.153

2.  Role of nucleotide excision repair and p53 in zidovudine (AZT)-induced centrosomal deregulation.

Authors:  Dariya Momot; Terri A Nostrand; Kaarthik John; Yvona Ward; Seth M Steinberg; David J Liewehr; Miriam C Poirier; Ofelia A Olivero
Journal:  Environ Mol Mutagen       Date:  2014-07-30       Impact factor: 3.216

3.  3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells.

Authors:  Roberta Santarelli; Chiara Pompili; Maria Saveria Gilardini Montani; Lorenzo Evangelista; Roberta Gonnella; Mara Cirone
Journal:  Pharmaceutics       Date:  2022-03-17       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.